Skip to content
healthcare.dev

Briviact

NDC 50474-970, brivaracetam, injection, suspension, from UCB, Inc..

Product NDC
50474-970
Status
Listed
Labeler
UCB, Inc.
Dosage form
INJECTION, SUSPENSION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA205837
DEA schedule
CV
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50474-970 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BRIVARACETAM50 mg/5mL

Pharmacologic classes

Epoxide Hydrolase Inhibitors [MoA]

Package NDCNDC-11Package
50474-970-755047409707510 VIAL, GLASS in 1 CARTON (50474-970-75) / 5 mL in 1 VIAL, GLASS (50474-970-63)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3cf2f439-0e97-443e-8e33-25ecef616f6c

Use it

Look up 50474-970 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50474-970 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50474-970. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.